Classes
Publications
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits2010 | Faculty of Medicine in Hradec Králové
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination +12007 | Faculty of Medicine in Hradec Králové
- Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH) +12007 | Faculty of Medicine in Hradec Králové
- A pilot study of matrix metalloproteinases on the model of daunorubicin-induced cardiomyopathy in rabbits +12007 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity and the possibility of the pharmacological cardioprotection2007 | Faculty of Medicine in Hradec Králové
- Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity +12006 | Faculty of Medicine in Hradec Králové
- Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits +12005 | Faculty of Medicine in Hradec Králové
- Study of potential cardioprotective effects of a novel iron chelator (pyridoxal 2-chlorobenzoyl hydrazone; o-108) in daunorubicin cardiotoxicity in rabbitsPublication without faculty affiliation
Loading network view...